In recent years, personalized or precision medicine has made effective inroads into the
management of diseases, including respiratory diseases. The route to implementing this …

Background Various risk assessment tools have been proposed to identify stable patients
with acute pulmonary embolism (PE) who are at high risk of early adverse outcome (ie …

Background Identification of patients with acute symptomatic pulmonary embolism (PE) who
are at low-risk for short-term complications to warrant outpatient care lacks clarity. Method In …

Background The effect of supplemental oxygen therapy in patients with intermediate-risk
pulmonary embolism (PE) who do not have hypoxemia at baseline is uncertain. Research …

En los últimos años la llamada «medicina personalizada o de precisión» ha irrumpido con
fuerza en el manejo de las enfermedades, entre ellas las respiratorias. La posibilidad de …

High-risk pulmonary embolism (PE) refers to a large embolic burden causing right
ventricular failure and hemodynamic instability. It accounts for approximately 5% of all cases …

Abstract Background The Composite Pulmonary Embolism Shock (CPES) score has been
developed to identify normotensive patients with acute pulmonary embolism (PE) and a low …

Introduction Although older adults represent a significant proportion of patients with venous
thromboembolism (VTE), the data on the impact of age-related differences in the clinical …

Abstract Background/Objective: Sleep-disordered breathing (SDB) may change from the
acute to stable phase of some cardiovascular disorders, but little is known whether these …

Background Right ventricle (RV) dysfunction increases the risk of death from pulmonary
embolism (PE). C-reactive protein (CRP) might identify RV inflammation and dysfunction in …